RNA interference (RNAi) is a natural mechanism used by the body to turn genes off without permanently changing DNA. It controls how and when genes are turned into proteins and is part of the innate immune response to viruses. RNAi occurs when a small RNA (a microRNA, small interfering RNA or antisense RNA) binds to messenger RNA (mRNA) and stops it from being turned into a protein product.
RNAi can turn off any gene in the genome and so is used in scientific research to discover the genetic cause of different diseases and in RNA medicines to treat diseases caused by too much protein or by defective proteins.
January 7, 2018
Arcturus Therapeutics to Present in a Panel Discussion at East/West CEO Conference Called “Challenges and Opportunities in Biotech” on Sunday, Jan 7th 2018, from 11:20 am - 11:50 am.
January 5, 2018
Johnson & Johnson Innovation Champions Leading Edge Science with 15 New Collaborations with Potential to Impact Patients' Lives
January 4, 2018
CureVac and Arcturus Therapeutics Announce Broad Strategic Collaboration to Advance Next Generation of Lipid-Mediated mRNA Therapeutics